Effects of sodium arsenite on the some laboratory signs and therapeutic role of thymoquinone in the rats

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 4, 2015, Pages 658-663

  Aras, S ^a   Gerin, F ^b   Aydin, B ^b   Ustunsoy, S ^c   Sener, U ^b   Turan, B C ^b   Armutcu, F ^d  

^a SIFA UNIVERSITY   (Turkey)

^b NAMIK KEMAL UNIVERSITY   (Turkey)

^c FATIH UNIVERSITY   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Inflammatory cytokines; Oxidative stress; Rats; Sodium arsenite; Thymoquinone

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ARSENITE SODIUM; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PROTEIN; SERUM ALBUMIN; SODIUM CHLORIDE; THYMOQUINONE; TRIACYLGLYCEROL; UREA; URIC ACID; ARSENOUS ACID DERIVATIVE; BENZOQUINONE DERIVATIVE; SODIUM DERIVATIVE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; ANIMAL; CELL PROTECTION; CHEMICALLY INDUCED; DRUG EFFECTS; LIVER; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ARSENITES; BENZOQUINONES; CYTOPROTECTION; INFLAMMATION; LIVER; MALE; MODELS, ANIMAL; NITRIC OXIDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; SODIUM COMPOUNDS;

EID: 84942305620     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. DAS N, PAUL S, CHATTERJEE D, BANERJEE N, MAJUMDER NS, SARMA N, SAU TJ, BASU S, BANERJEE S, MAJUMDER P, BANDYOPADHYAY AK, STATES JS, GIRI AK. Arsenic exposure through dr inking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India. BMC Public Health 2012; 12: 639.
2. SAHA JC, DIKSHIT AK, BANDYOPADHYAY M, SAHA KC. A review of arsenic poisoning and its effects on human health. Crit Rev Env Sci Tec 1999; 29: 281-313.
3. DANGLEBEN NL, SKIBOLA CF, SMITH MT. Arsenic immunotoxicity: a review. Environ Health 2013; 12: 73.
4. SIMEONOVA PP, LUSTER MI. Arsenic and atherosclerosis. Toxicol Appl Pharmacol 2004; 198: 444-449.
5. JOMOVA K, JENISOVA Z, FESZTEROVA M, BA ROS S, LISKA J, HUDECOVA D, RHODES CJ, VALKO M. Arsenic: toxicity, oxidative stress and human disease. J Appl Toxicol 2011; 31: 95-107.
6. SRIVASTAVA S, VLADYKOVSKAYA EN, HABERZETTL P, SITHU SD, D'SOUZA SE, STATES JC. Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/-mice. Toxicol Appl Pharmacol 2009; 241: 90-100.
7. WU MM, CHIOU HY, HO IC, CHEN CJ, LEE TC. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ Health Perspect 2003; 111: 1429-1438.
8. LEE PC, HO IC, LEE TC. Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells. Toxicol Sci 2005; 85: 541-550.
9. JAVEED A, ZHAO Y, ZHAO Y. Macrophage-migration inhibitory factor: role in inflammatory diseases and graft rejection. Inflamm Res 2008; 57: 45-50.
10. WOO CC, KUMAR AP, SETHI G, TAN KH. Thymoquinone: Potential cure for inflammatory disorders and cancer. Biochem Pharmacol 2012; 83: 443-451.
11. ARSLAN SO, GELIR E, ARMUTCU F, COSKUN O, GUREL A, SAYAN H, CELIK IL. The protective effect of thymoquinone on ethanol-induced acute gastric damage in the rat. Nutr Res 2005; 25: 673-680.
12. CORTAS NK, WAKID NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmiumreduction method. Clin Chem 1990; 36: 1440-1443.
13. MESSARAH M, SAOUDI M, BOUME NDJEL A, KADECHE L, BOULAKOUD MS, EL FEKI A. Green tea extract alleviates arsenic-induced biochemical toxicity and lipid peroxidation in rats. Toxicol Ind Health 2013; 29: 349-359.
14. TANDAN N, ROY M, ROY S. Ameliorative Potential of Psidium guajava on Hemato-biochemical Alterations in Arsenic-exposed Wistar Rats. Toxicol Int 2012; 19: 121-124.
15. MESSARAH M, KLIBET F, BOUMENDJEL A, ABDENNOUR C, BOUZERNA N, BOULAKOUD MS, EL FEKI A. Hepatoprotective role and antioxidant capacity of selenium on arsenic-induced liver injury in rats. Exp Toxicol Pathol 2012; 64: 167-174.
16. ) PERAZA MA, CARTER DE, GANDOLFI AJ. Toxicity and metabolism of subcytotoxic inorganic arsenic in human renal proximal tubule epithelial cells (HK-2). Cell Biol Toxicol 2003; 19: 253-264.
17. STR AUB AC, STOLZ DB, ROSS MA, HERNANDEZ-ZAVALA A, SOUCY NV, KLEI LR, BARCHOWSKY A. Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver. Hepatology 2007; 45: 205-212.
18. SCHUHMACHER-WOLZ U, DIETER HH, KLEIN D, SCHNEIDER K. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects. Crit Rev Toxicol 2009; 39: 271-298.
19. REHMAN K, NARANMANDURA H. Double-edged effects of arsenic compounds: anticancer and carcinogenic effects. Curr Drug Metab 2013; 14: 1029-1041.
20. CACIARI T,CAPOZZELLA A,TOMEI F,NIETO HA,DE SIO S,MONTUORI L,SCHIFANO MP,ANDREOZZI G,FIASCHETTI M,TOMEI G,CIARROCCA M. Arsenic and peripheral blood count in workers exposed to urban stressors Clin Ter 2012 163: e293-302.
21. NAVAS-ACIEN A, SHARRETT AR, SILBERGELD EK, SCHWARTZ BS, NACHMAN KE, BURKE TA, GUALLAR E. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 2005; 162: 1037-1049.
22. WU F, MOLINARO P, CHEN Y. Arsenic exposure and subclinical endpoints of cardiovascular diseases. Curr Environ Health Rep 2014; 1: 148-162.
23. BANERJEE N, BANERJEE S, SEN R, BANDYOPADHYAY A, SARMA N, MAJUMDER P, DAS JK, CHATTERJEE M, KABIR SN, GIRI AK. Chronic arsenic exposure impairs macrophage functions in the exposed individuals . J Clin Immunol 2009; 29: 582-594.
24. LEMARIE A, BOURDONNAY E, MORZADEC C, FARDEL O, VERNHET L. Inorganic arsenic activates reduced NADPH oxidase in human primary macrophages through a Rho kinase/p38 kinase pathway. J Immunol 2008; 180: 6010-6017.
25. WU F, JASMINE F, KIBRIYA MG, LIU M, CHENG X, PARVEZ F, PAUL-BRUTUS R, PAUL RR, SARWAR G, AHMED A, JIANG J, ISLAM T, SLAVKOVICH V, RUNDEK T, DEMMER RT, DESVARIEUX M, AHSAN H, CHEN Y. Interaction between arsenic exposure from drinking water and genetic susceptibility in carotid intima-media thickness in Bangladesh. Toxicol App l Pharmacol 2014; 276: 195-203.
26. HSUEH WA, LAW RE. PPARgamma and atherosclerosis: effects on cell growth and movement. Arterioscler Thromb Vasc Biol 2001; 21: 1891-1895.
27. MANNA P, SINHA M, SIL PC. Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid. Arch Toxicol 2008; 82: 137-149.
28. EL GAZZAR M, EL MEZAYEN R, MARECKI JC, NICOLLS MR, CANASTAR A, DRESKIN SC. Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. Int Immunopharmacol 2006; 6: 1135-1142.
29. HAMDY NM, TAHA RA. Effects of Nigella sativa oil and thymoquinone on oxidative stress and neuropathy in streptozotocin-induced diabetic rats. Pharmacology 2009; 84: 127-134.
30. NAGI MN, ALAM K, BADARY OA, AL-SHABANAH OA, ALSAWAF HA, AL-BAKAIRI AM. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Biol Int 1999; 47: 153-159.
31. FOUAD AA, ALBUALI WH, JRESAT I. Protective effect of thymoquinone against arsenic-induced testicular toxicity in rats. Int J Med Health Pharm Biomed Eng 2014; 2: 92-95.
32. ELSHERBINY NM, EL-ELSHERBINY M. Thymoquinone attenuates Doxorubicin-induced nephrotoxicity in rats: Role of Nrf2 and NOX4. Chem Biol Interact 2014; 223C: 102-108.
33. SAYED AA. Thymoqu inone and proanthocyanidin attenuation of diabetic nephropathy in rats. Eur Rev Med Pharmacol Sci 2012; 16: 808-815.
34. CHEHL N, CHIPITSYNA G, GONG Q, YEO CJ, ARAFAT HA. Anti-inflammatory e ffects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) 2009; 11: 373-381.
35. RAGHEB A, ELBARBRY F, PRASAD K, MOHAMED A, AHMED MS, SHOKER A. Att enuation of the development of hypercholesterolemic atherosclerosis by thymoquinone. Int J Angiol 2008; 17: 186-192.